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Abstract
AIM: To investigate the role of psychological character-
istics as risk factors for oesophageal adenocarcinoma 
(OAC), as well as the reflux-mediated precursor path-
way. 
METHODS: An all-Ireland population-based case-con-
trol study recruited 230 reflux oesophagitis (RO), 224 
Barrett’s oesophagus (BO) and 227 OAC patients and 
260 controls. Each case/control group completed mea-
sures of stress, depression, self-efficacy, self-esteem, 
repression and social support. A comparative analysis 
was undertaken using polytomous logistic regression 
adjusted for potential confounders. 
RESULTS: Compared to controls, OAC patients were 
almost half as likely to report high stress levels over 
their lifetime (P = 0.010, OR 0.51; 95%CI: 0.29-0.90) 
and 36% less likely to report having experienced de-
pression (OR 0.64; 95%CI: 0.42-0.98). RO patients 
reported significantly higher stress than controls par-
ticularly during middle- and senior-years (P  for trends 
< 0.001). RO patients were 37% less likely to report 
having been highly emotionally repressed (OR 0.63; 
95%CI: 0.41-0.95). All case groups (OAC, RO and 
BO) were more likely than controls to report having 
had substantial amounts of social support (OR 2.84; 
95%CI: 1.63-4.97; OR 1.97; 95%CI: 1.13-3.44 and OR 
1.83; 95%CI: 1.03-3.24, respectively).
CONCLUSION: The improved psychological profile of 
OAC patients may be explained by response shift. The 
role of psychological factors in the development of OAC 
requires further investigation.
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Gastro-oesophageal reflux comprises a series of  chronic 
symptoms caused by abnormal reflux of  gastric and in-
testinal digestive juice[1] which may cause inflammation 
of  the oesophageal mucosa reflux oesophagitis (RO)[2] or 
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distal oesophagus Barrett’s oesophagus (BO)[3]. Prevalence 
rates for gastro-oesophageal reflux disease in western 
countries range from 10%-20%[4,5]. Incidence of  BO in 
Northern Ireland is 567/100  000 of  the population (un-
published data, Northern Ireland BO Registry). Although 
the absolute risk remains low (0.5% per patient per year)[6], 
BO confers an increased risk of  developing oesophageal 
adenocarcinoma (OAC)[7], the incidence of  which has in-
creased by 600% in western countries in recent decades[8]. 
The incidence rate for oesophageal cancer in Northern 
Ireland is similar to rates reported elsewhere[9].
Previous studies have found associations between 
hypothesized risk factors including diet, obesity and 
smoking[10-14] and the development of  OAC though the 
demographic distribution of  risk factors does not fully 
align with OAC incidence[15]. Stress appears to affect 
the neuroendocrine and immune systems as well as the 
sympathetic nervous system[16,17]. In population-based 
studies, job strain-related stress has been positively as-
sociated with symptomatic reflux and an increased risk 
of  OAC[17-19]. However, the role of  psychosocial factors 
in the development of  OAC and it’s precursor lesions has 
not been investigated. 
Data from an all-Ireland population-based, case-con-
trol study (the FINBAR Study) was used to investigate 
the nature and extent to which different psychosocial 
factors (e.g., stress and depressed mood) affected the de-
velopment of  OAC, including the influence such factors 
may have on the reflux-mediated precursor pathway. 
MATERIALS AND METHODS
The FINBAR study was an all-Ireland population-based 
case-control study comprising three patient groups with 
(1) OAC; (2) long-segment BO; and (3) RO and a group 
of  normal population controls. All participants were Cau-
casian and aged between 35-85 years. The design of  the 
FINBAR Study has been described elsewhere[10,20]. Briefly, 
OAC cases had histological confirmation of  adenocarci-
noma within the oesophagus. They were identified using 
electronic pathology records from all pathology labora-
tories in Northern Ireland and from the main hospitals 
involved in the treatment of  oesophageal cancer in the 
Republic of  Ireland. BO patients had histological con-
firmation of  specialized intestinal metaplasia within the 
oesophagus and at least 3 centimeters of  BO observed at 
endoscopy. RO patients were those diagnosed with mac-
roscopically visible erosive oesophagitis (grades 2-4 in the 
Savary Miller/Hetzel-Dent classification or grades B, C 
or D in the Los Angeles classification) at upper gastro-
intestinal (GI) endoscopy. BO and RO patients were fre-
quency matched (within 5-year age- and sex-strata) to the 
distribution of  OAC patients. Control subjects had no 
history of  oesophageal or other GI cancer or BO. They 
were frequency matched by sex, and 5-year age bands to 
OAC patients. 
For the psychosocial assessment patients were asked 
to reflect on their life as a whole when answering the 
questions. Self-perceived stress or daily strain was as-
sessed using the 4-item Reed Stress Inventory. Responses 
to items were scored as follows: 0, no response on one 
or more statements; 1, “not at all” for all four state-
ments; 2, “not at all” for any three statements with any 
other response for the fourth; 3, “not at all” for any two 
statements with “hardly true” for the other two; 4, “not 
at all” for any one or two statements with any other re-
sponses for the remainder but not those for a score of  
3; 5, all other response sets not specified under 0, 1, 2, 3, 
4, 6, 7 or 8; 6, “moderately true” to all four statements, 
or “moderately true” for three statements with “exactly 
true” for the fourth; 7, “exactly true” for any three state-
ments with “moderately true” or “hardly true” for the 
fourth; and 8, “exactly true” in response to all four state-
ments. Scores from 1 to 8 were categorised as represent-
ing high (6-8), medium (4-5), or low (1-3) levels of  stress. 
A 4-part item was used to assess self-reported stress 
across the lifespan from: (1) childhood/teenager (up to 
19 years); (2) young adulthood (20-39 years); (3) midlife 
(40-59 years); and (4) senior or later years in life (60-85 
years). Each life period was considered a separate vari-
able in the analyses in order to gauge approximately the 
extent to which any particular developmental period in an 
individual’s life had been stressful and to assess its signifi-
cance for patients compared to controls. 
Depressed mood was assessed using an adapted 2-item 
case-finding instrument[21]. A score of  1-2 on either ques-
tion indicated a “not depressed” status while a score of  
3-4 on either question indicated that the respondent was 
likely to be “depressed” or to have a depressed mood. 
Self-efficacy and coping ability were measured using 
a 10-item scale designed to assess the extent to which a 
respondent had a self-belief  that they had the capacity 
to overcome difficult tasks and cope with adversity. Re-
sponses on the 4-point likert scale were summed yielding 
a score of  between 10 and 40 in the direction of  increas-
ing self-efficacy and coping ability. Self-efficacy was cat-
egorized as low (scores of  10-29), medium (30-34) and 
high (35-40) based on the tertile distribution of  scores 
among the controls. 
A single-item was used to measure self-esteem with a 
score of  1-2 indicating low self-esteem and a score of  3-4 
indicating high self-esteem.
A single-item was used to assess emotional repression. 
A high score (3-4) indicated a tendency to share feelings 
and emotions relatively easily and a low score (1-2) was 
endorsed by respondents who were reticent or repressive 
in nature. 
The responses to three questions on social support 
and loneliness were summed and categorized as indicat-
ing varying degrees of  support from hardly any (scores 
0-8), some (score 9), moderate (score 10) and substantial 
(scores 11-12) based on the quartile distribution of  scores 
among the control group. 
Ethical approval
Ethical approval for the FINBAR study was obtained 
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from the Research Ethics Committee of  the Queen’s Uni-
versity Belfast, the Clinical Research Ethics Committee 
of  the Cork Teaching Hospitals and the Research Ethics 
Committee Board of  St. James’s Hospital, Dublin.
Statistical analysis
Group t-tests and Pearson χ 2 tests were used to compare 
cases and controls. Polytomous multivariate logistic re-
gression was used to compare the psychosocial factors 
in each case group with the control group, adjusting 
for potential confounders including gender, age, years 
of  full-time education, job type (manual, non-manual), 
Gastroesophageal reflux (GOR) symptoms (never, ever), 
smoking status (never, ex-smoker, current smoker), al-
cohol consumption (g/d) and BMI (self-reported weight 
5-years before interview divided by height measured at 
interview). 
RESULTS
In total, 227 OAC patients, 224 BO patients, 230 RO pa-
tients and 260 controls were recruited into the study with 
participation rates of  64%, 82%, 69% and 42% respec-
tively. Case groups and controls were similar regarding 
gender and age due to frequency matching. Other charac-
teristics are displayed in Table 1. 
There were no significant trends between reported 
stress levels as measured by the Reed Stress Inventory 
and risk of  RO or BO (Table 2). However, OAC patients 
were half  as likely to report high stress than controls (OR 
0.51; 95%CI: 0.29-0.90). Stress levels were similar dur-
ing childhood/teenage years for RO, BO, OAC cases and 
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Table 1  Characteristics of participants
Variables Controls RO BO OAC
n (%) n  (%) P  value n  (%) P  value n  (%) P  value
Gender 
  0.47  0.55  0.99   Male  220 (84.6) 189 (82.2)   185 (82.6)  192 (84.6)
   Female    40 (15.4)   41 (17.8)    39 (17.4)    35 (15.4)
 
Age (yr) 63.0 61.7   0.22 62.4  0.57 64.2  0.28
Education (yr) 12.0 10.8 < 0.001 11.3  0.01 10.7 < 0.001
Job type
  0.71  0.02  0.01   Manual  119 (48.0) 107 (48.2)  130 (59.1)  128 (59.5)
   Non-manual  129 (52.0) 115 (51.8)    90 (40.9)    87 (40.5)
GOR symptoms
< 0.001 < 0.001 < 0.001   Never  211 (81.2) 140 (60.9)    60 (26.8)  117 (51.5)
   Ever    49 (18.8)   90 (39.1)  164 (73.2)  110 (48.5)
Smoking status
  0.03  0.40 < 0.001
   Never  102 (40.2) 109 (48.4)    87 (39.2)    45 (20.4)
   Ex-smoker  107 (42.1)   68 (30.2)    85 (38.3)    99 (44.8)
   Current    45 (17.7)   48 (21.3)    50 (22.5)    77 (34.8)
Alcohol (g/d) 26.1 22.0   0.15 22.3  0.21 19.2 0.01
Body mass index (kg/m2) 27.0 27.8   0.05 27.0  0.90 28.7 < 0.001
Reed stress inventory, mean ± SD
    0.014    0.187 < 0.001
Mean score (range 2-8) 4.50 ± 2.08 4.11 ± 1.88 4.28 ± 2.08 3.80 ± 2.09
Stress teenage years
    0.146    0.539    0.655
Mean score (range 1-5) 1.80 ± 1.05 1.67 ± 0.95 1.86 ± 1.18 1.85 ± 1.17
Stress young adulthood
    0.301    0.328    0.486
Mean score (range 1-5) 2.45 ± 1.23 2.67 ± 1.11 2.34 ± 1.25 2.37 ± 1.24
Stress midlife
< 0.001    0.038    0.928
Mean score (range 1-5) 2.49 ± 1.26 3.33 ± 1.20 2.75 ± 1.34 2.50 ± 1.33
Stress senior years
< 0.001  0.08    0.088
Mean score (range 1-5) 2.07 ± 1.17 2.80 ± 1.42 2.34 ± 1.35 2.33 ± 1.37
Depression
    0.107    0.147    0.109
Mean score (range 2-8) 4.11 ± 1.74 4.42 ± 2.37 4.38 ± 2.25 3.82 ± 2.31
Self efficacy
< 0.001    0.794 < 0.001
Mean score (range 10-40) 32.0 ± 4.76 33.8 ± 4.32 31.8 ± 5.52 34.3 ± 4.89
Self esteem
    0.828    0.022    0.034
Mean score (range 1-4) 2.95 ± 0.81 2.93 ± 1.10 2.76 ± 1.04 3.13 ± 0.97
Repression
    0.097    0.501    0.554
Mean score 2.80 ± 0.89 2.64 ± 1.17 2.86 ± 1.05 2.86 ± 1.17
Social support 
< 0.001  0.40 < 0.001
Mean score (range 1-4) 3.57 ± 0.60 3.82 ± 0.50 3.62 ± 0.63 3.76 ± 0.48
RO: Reflux oesophagitis; BO: Barrett’s oesophagus; OAC: Oesophageal adenocarcinoma; GOR: Gastroesophageal reflux. 
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DISCUSSION
This is the first study to investigate psychological char-
acteristics of  RO, BO and OAC patients as possible risk 
factors for the development of  these conditions. OAC 
patients compared to controls reported significantly lower 
stress levels throughout their life in contrast to compari-
sons between RO and BO patients and controls. RO 
patients reported significantly higher stress levels in later 
life. OAC patients were also less likely than controls to 
report depression and to have higher (albeit non-signif-
icant) self-esteem and significantly better coping skills. 
All three case groups reported more social support than 
controls. 
It has been hypothesized that psychosocial factors 
such as stress and social support may mediate or moder-
ate cancer risk through, for example, influencing neuroen-
docrine and immune functioning[22]. Long-term exposure 
to stress causes persistent activation of  the hypothalamic-
pituitary-adrenal axis reducing tumour suppressor capa-
bility and suppressing DNA repair functions[23-26] through 
suppression of  lymphocyte activity[27] and cytotoxic T-cell 
controls, respectively. Regarding young adulthood, there 
was a significant trend between having RO and reported 
stress; RO cases also reported significantly much higher 
stress during middle- and senior-years than controls (al-
most 10-fold and 6-fold more, respectively) with a signifi-
cant linear trend (P for trend < 0.001) observed for each 
point on the life-span stress scale.
OAC cases were 36% less likely than controls to re-
port depression; no significant association was observed 
between depression and BO or RO (Table 3). Self-
efficacy levels were 3-times higher in RO patients and 
2-times higher in OAC patients compared to controls. No 
significant association was observed for self-efficacy and 
BO. OAC patients were 58% more likely than controls to 
report high self-esteem though the association was not 
statistically significant (95%CI: 0.99-2.52). Self-esteem did 
not differ significantly between RO or BO cases respec-
tively and controls. RO patients were 37% less likely than 
controls to report being repressed; significant associa-
tions were not observed between repression and BO or 
OAC status. RO, BO and OAC patients were more likely 
to report high levels of  social support than controls. 
Table 2  Self-reported stress levels during lifetime
Controls RO BO OAC
Stress levels n  (%) n  (%) AOR (95%CI) n  (%) AOR (95%CI) n  (%) AOR (95%CI)
Reed stress inventory levels
   Low   45 (17.6)   63 (27.9) 1.00   60 (27.2) 1.00    81 (36.3) 1.00
   Medium 154 (60.2) 122 (54.0) 0.92 (0.51-1.63) 102 (46.2) 0.51 (0.31-0.86)    91 (40.8) 0.37 (0.23-0.61)
   High   57 (22.3)   41 (18.1) 1.43 (0.64-3.22)   59 (26.7) 0.60 (0.33-1.09)    51 (22.9) 0.51 (0.29-0.90)
P for trend 0.48 P for trend 0.10 P for trend 0.010
Teenage years
   1 135 (52.7) 132 (58.7) 1.00 122 (55.5) 1.00   127 (57.5) 1.00
   2   67 (26.1)   53 (23.6) 1.05 (0.64-1.71)   42 (19.1) 0.73 (0.43-1.23)    32 (14.5) 0.63 (0.37-1.06)
   3   31 (14.1)   26 (11.6) 0.77 (0.40-1.49)   31 (14.1) 1.06 (0.57-1.96)    42 (19.0) 1.50 (0.84-2.67)
   4 16 (6.3) 11 (4.9) 0.67 (0.26-1.70) 14 (6.4) 0.75 (0.31-1.79)    9 (4.1) 0.58 (0.23-1.48)
   5   7 (2.7)   3 (1.3) 0.28 (0.06-1.26) 11 (5.0) 0.76 (0.25-2.29)  11 (5.0) 1.18 (0.40-3.48)
P for trend 0.10 P for trend 0.55 P for trend 0.85
Young adulthood
   1    64 (25.0)   38 (16.9) 1.00   76 (34.7) 1.00    70 (32.3) 1.00
   2   67 (26.2)   61 (27.1) 2.04 (1.11-3.76)   47 (21.5) 0.59 (0.34-1.04)    52 (24.0) 0.80 (0.47-1.38)
   3   82 (32.0)   75 (33.3) 1.92 (1.06-3.49)   57 (26.0) 0.47 (0.27-0.81)    55 (25.4) 0.67 (0.39-1.14)
   4   32 (12.5)   39 (17.3) 2.65 (1.27-5.55)   23 (10.5) 0.46 (0.22-0.96)    24 (11.1) 0.71 (0.35-1.44)
   5  11 (4.3) 12 (5.3) 3.20 (1.07-9.55) 16 (7.3) 0.86 (0.33-2.28)  16 (7.4) 1.22 (0.47-3.18)
P for trend 0.01 P for trend 0.05 P for trend 0.49
Midlife
   1    68 (28.7) 20 (9.1) 1.00   52 (25.0) 1.00    58 (27.9) 1.00
   2   57 (24.1)   38 (17.2) 2.56 (1.22-5.37)   39 (18.8)  0.87 (0.48-1.59)    62 (29.8) 1.25 (0.73-2.16)
   3   55 (23.2)   50 (22.6) 4.04 (1.97-8.25)   48 (23.1) 1.07 (0.59-1.94)    38 (18.3) 0.95 (0.53-1.71)
   4   41 (17.3)   76 (34.4)   8.50 (4.14-17.46)   47 (22.6) 1.23 (0.65-2.30)    25 (12.0) 0.70 (0.36-1.36)
   5 16 (6.8)   37 (16.7)   9.82 (4.11-23.45)   22 (10.6) 1.27 (0.55-2.89)    25 (12.0) 1.60 (0.72-3.53)
P for trend 0.001 P for trend 0.33 P for trend 0.97
Senior years
   1   64 (42.4)   30 (24.4) 1.00   47 (39.2) 1.00    47 (37.3) 1.00
   2   38 (25.1)   28 (22.8) 1.76 (0.86-3.61)   23 (19.2) 0.71 (0.35-1.45)    32 (25.4) 1.08 (0.56-2.09)
   3   30 (19.9)   22 (17.9) 1.77 (0.82-3.83)   22 (18.3) 0.93 (0.44-1.96)    19 (15.1) 0.84 (0.40-1.78)
   4 12 (8.0)   23 (18.7)   4.28 (1.72-10.67)   18 (15.0) 2.15 (0.85-5.43)    14 (11.1) 1.71 (0.67-4.35)
   5   7 (4.6)   20 (16.3)   5.92 (1.72-16.77) 10 (8.3) 1.48 (0.48-4.54)    14 (11.1) 2.35 (0.82-6.70)
P for trend 0.001 P for trend 0.20 P for trend 0.14
RO: Reflux oesophagitis; BO: Barrett’s oesophagus; OAC: Oesophageal adenocarcinoma; 1: Low; 2-4: Medium; 5: High; AOR: Adjusted odds ratio. 
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and natural killer cell activity[28,29]. However, perceived 
stress over one’s lifetime appeared to be significantly low-
er in OAC patients. Other factors such as recall bias and 
response shift may explain these reported lower levels of  
stress. Retrospective reporting may be skewed by recall 
bias as patients may lose their memory trace with time 
and their salience following a cancer diagnosis. Also, the 
current study identified an overall positive psychological 
profile among OAC patients including less depression, 
higher self-efficacy, higher self-esteem and more social 
support. The phenomenon of  “response shift” may help 
to explain the findings in so far as a perceptual adjust-
ment may occur in how a patient views stress or adversity 
and friends; and family tend to be sympathetic, caring 
and more likely to offer support at times of  illness[30-32]. 
Furthermore, a “cancer experience” has the potential to 
effect positive psychological change or post-traumatic 
growth (PTG)[33]. For example, studies have found that 
PTG is inversely associated with emotional distress[34] and 
positively associated with happiness[35]. The majority of  
studies that have investigated the role of  PTG have been 
conducted with patients with breast cancer, a form of  
cancer which has relatively high survival rates. In Europe, 
five and ten year survival rates of  women diagnosed with 
breast cancer between 2000 and 2002 were 82% and 
72%, respectively[35]. In contrast, survival rates for OAC 
patients are much lower between 13% and 17% for males 
and females, respectively, in Ireland[36]. A diagnosis of  a 
cancer such as OAC with a poor prognosis and survival 
rate might be expected to result in despair, pessimism, re-
duce active coping and increase dependence on more an 
emotional-based style; and, in turn, these factors might be 
expected to reduce potential for PTG. In addition, OAC 
presents a unique symptom complex and the psychoso-
cial issues and disabilities that arise from the treatment 
modalities involved with this cancer might be expected 
to influence a patient’s benefit finding ability and dimin-
ish their capacity for PTG. However, this study - the first 
to investigate PTG and response shift in OAC patients - 
suggests that benefit finding and positive well-being may 
be experienced by OAC patients despite the often hope-
less prognosis. High levels of  self-efficacy reported by 
OAC patients may serve to regulate the stress process, 
relieve depression and improve cancer symptoms[37,38]. 
For example, OAC patients were less depressed than 
controls (OR 0.64; 95%CI: 0.42-0.98).
Perceived stress was higher in RO patients (particularly 
among older patients) in line with other studies [that dem-
onstrate a link between psychosocial factors and gastro-
oesophageal reflux disease (GORD)[19,39]] even though RO 
patients were more likely than controls to report high self-
efficacy. The association between GORD and somatisa-
tion disorder and depression reported elsewhere[40] was 
not supported by the results of  this study. The voluntary 
self-selection to participate in the study may have led to 
a form of  ascertainment bias, whereby individuals with 
lower self-efficacy may have been less likely to participate 
in the study. Also, recall bias may have over-reported prior 
levels of  self-efficacy, based on their current ability to 
cope with adversity. 
Repression has been linked with poor health and 
cancer[41-45]. However, there was no significant associa-
tion found between repression and OAC. The single-item 
measure of  repression used in this study may not have 
been sufficiently sensitive[46]. RO patients were less likely 
than controls to report high repression. This relationship 
may have been moderated by social support - RO pa-
tients were more likely than controls to report that they 
had good social support.
This is a large, all-Ireland, population-based study, for 
which there was a relatively high response rate among 
case groups. The low control group response rate (42%), 
Table 3  Psychosocial factors by group status
Controls RO BO OAC
n (%) n  (%) AOR (95%CI) n  (%) AOR (95%CI) n  (%) AOR (95%CI)
Depression
   No 163 (63.7) 131 (58.0) 1.00 118 (52.2) 1.00 147 (65.9) 1.00
   Yes   93 (36.3)   95 (42.0)  0.92 (0.61-1.40) 104 (46.9) 1.12 (0.74-1.70)   76 (34.1) 0.64 (0.42-0.98)
Self-efficacy
   Low 84 35 1.00 79 1.00 43 1.00
   Medium 74 55  1.65 (0.92-2.98) 54 0.61 (0.36-1.05) 49  1.06 (0.60 -1.87)
   High 97 135  3.14 (1.86-5.31) 86 0.78 (0.48-1.27) 128  2.17 (1.32- 3.57)
Self-esteem
   Low   67 (26.2)   63 (27.9) 1.00   77 (35.0) 1.00   46 (20.6) 1.00
   High 189 (73.4) 163 (72.1)    0.93 (0.59 - 1.47) 143 (65.0)  0.76 (0.48 -1.18) 177 (79.4)   1.58 (0.99 - 2.52)
Repression
   Low   83 (32.4) 100 (44.4) 1.00   71 (32.0) 1.00  72  (32.3) 1.00
   High 173 (67.6) 125 (55.6)  0.63 (0.41-0.95) 151 (68.0)  1.20 (0.78 -1.86) 151 (67.7) 1.10 (0.72-1.67)
Social support
   Hardly any 89 78 1.00 77 1.00 60 1.00
   Some 89 53  0.72 (0.43-1.21) 61 1.12 (0.67-1.86) 58 1.28 (0.77-2.14)
   Moderate 37 30  0.93 (0.49-1.77) 30 1.26 (0.66-2.39) 38 1.89 (1.02-3.48)
   Substantial 41 64  1.97 (1.13-3.44) 54 1.83 (1.03-3.24) 67 2.84 (1.63-4.97)
RO: Reflux oesophagitis; BO: Barrett’s oesophagus; OAC: Oesophageal adenocarcinoma; AOR: Adjusted odds ratio. 
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however, merits a cautious approach to the interpreta-
tion of  results (e.g., representativeness of  the population) 
though adjusted analyses were performed on potential 
confounders such as GOR, gender, age at interview, 
smoking status, alcohol consumption, occupation and 
BMI. 
The retrospective nature of  this study meant that it 
was susceptible to recall bias; this problem may be over-
come by using a prospective study design. The resource-
heavy nature, however, of  these kinds of  studies means 
that a retrospective study design, which can generate 
large data sets relatively quickly and efficiently, is usually 
more practicable. In any case, the incidence of  OAC is 
still relatively low[8] and the sample population is not large 
enough for a prospective study.
In conclusion, our results suggest that there may be 
a complex interaction between psychological factors re-
garding the development of  RO, BO and OAC. Further-
more, the results presented here indicate that these condi-
tions have significant psychological health consequences. 
Further research with enhanced methodological rigor is 
required to clarify the role of  psychological factors in the 
development of  OAC. 
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